The growth of the market is attributed to rising healthcare expenditure and high foley catheters demand. However, alternative treatments of urinary incontinence restrict the market growth.
The increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases (CVDs), cancer, stroke, bladder cancer, prostate cancer, and kidney diseases, is expected to increase the number of surgical procedures across the world. As per the World Health Organization (WHO), cardiovascular diseases are the leading cause of mortality and result in the deaths of ~17.9 million people every year globally. Moreover, according to the International Diabetes Federation's Diabetes Atlas 9th edition 2019, ~463 million adults aged 20–79 years had diabetes in 2019, and the number is projected to reach 700 million by 2045. Such a high prevalence of chronic conditions drives the number of surgical procedures, ultimately boosting the silicone-based catheters market.
In recent years, there have been considerable developments in the field of medicine. The increasing number of surgical procedures have increased the demand for urinary catheterization. Silicone-based catheters are used to keep the bladder empty during and after the surgical procedure. In urological surgery or other surgery on contiguous structures of the genitourinary tract, the prolonged duration of the surgery, usage of large-volume infusions or diuretics during surgery and need for monitoring of intraoperative urinary output are among the major factors increasing the demand for silicone based catheters.
According to a report published by the Lancet Commission on Global Surgery (2015), ~28–32% of the disease burden can be attributed to surgically treatable conditions globally, and 143 million additional surgical procedures are required to reduce mortality every year. The increasing awareness among the patient population for surgeries is driving the demand for surgical procedures to treat sudden unmet medical conditions; this is expected to propel the growth of the silicone based catheters market.
The Europe silicone based catheters market, based on application, is segmented into urinary tract infection (UTI)/catheter acquired urinary tract infection (CAUTI), surgery on contiguous structures of the genitourinary tract, prostate gland surgery, spinal cord injury, and others. The market, based on usage, is segmented into male, female, and pediatric. The Europe silicone based catheters market, by tip, is bifurcated into Nelaton tip and Tiemann tip. The market, based on product type, is segmented into short term Foley catheters, long term Foley catheters, and others. The Europe silicone based catheters market, based on type, is bifurcated into 2 way sizes: 6 to 26 Fr and 3 way sizes: 16 to 26 Fr. The market, based on end user, is segmented into hospitals, nursing homes and clinics, ambulatory surgical centers, and others. By country, the Europe silicone based catheters market is segmented into Germany, Italy, Spain, the UK, France, and the rest of Europe.
Teleflex Incorporated, B. Braun Melsungen AG, ConvaTec Group Plc, Ribbel International Limited, Bactiguard, BD, Cook Medical LLC, Angiplast, Sterimed Group, Medasil Surgical Limited, and Mais India are among the leading companies operating in the Europe silicone based catheters market.